CollPlant Biotechnologies Ltd.
CLGN
$0.37
$0.000.27%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -3.21M | -3.35M | -1.45M | -3.88M | |
| Total Depreciation and Amortization | 216.00K | 229.00K | 244.00K | 242.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -32.00K | 272.00K | 385.00K | 354.00K | |
| Change in Net Operating Assets | 88.00K | 406.00K | -344.00K | -182.00K | |
| Cash from Operations | -2.94M | -2.44M | -1.17M | -3.46M | |
| Capital Expenditure | -15.00K | -3.00K | -9.00K | -59.00K | |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 1.00K | 1.00K | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | 0.00 | |
| Cash from Investing | -15.00K | -3.00K | -8.00K | -58.00K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 0.00 | 3.10M | -- | 0.00 | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 0.00 | 3.10M | -- | 0.00 | |
| Foreign Exchange rate Adjustments | -6.00K | 40.00K | 1.00K | 60.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -2.96M | 699.00K | -1.17M | -3.46M | |